Navigation Links
Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
Date:9/17/2007

IND Allowed by FDA for Bioequivalence Program Starting in Normal Volunteers

BERKELEY HEIGHTS, N.J., Sept. 17 /PRNewswire-FirstCall/ -- Genta Inc. (Nasdaq: GNTA) announced that the Food and Drug Administration (FDA) has allowed the Investigational New Drug (IND) exemption that was submitted by the Company for its new drug known as G4544. In addition, Genta also announced that the first cohort of 6 normal volunteers has been treated with single doses of G4544 without experiencing significant side effects.

G4544 is a new tablet formulation that enables oral absorption of the active ingredient contained in Ganite(R) (gallium nitrate injection), a drug that is marketed by Genta and approved in the U.S. for treatment of cancer- related hypercalcemia that is resistant to hydration. The initial clinical study is a dose-ranging, single-dose evaluation of G4544 that will examine safety and pharmacokinetics of G4544 in human subjects. Genta is the IND Sponsor and is directing the clinical development program.

"The active ingredient in G4544 has shown a consistently high level of clinical activity across a range of skeletal diseases," said Dr. Raymond P. Warrell, Jr., Chairman and Chief Executive Officer of Genta. "Heretofore, an inconvenient dosing schedule has precluded broader use of the IV drug, which may now be resolved with the new oral formulation. We believe that emerging safety issues, such as osteonecrosis, that have been associated with the major competitive drug class of bisphosphonates, can be avoided with G4544. From a regulatory standpoint, we seek to establish bioequivalence to our IV drug, while conducting the additional preclinical and clinical studies to develop repeat-dose programs that may lead
'/>"/>

SOURCE Genta Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
3. Malvern initiates European user group meetings for chemical imaging
4. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
5. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
6. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
7. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
8. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
9. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ... Executive Officer, will be presenting at the 26 th ... Hotel in New York . The formal ... PM ET. In addition, Mr. Krakauer and Jorgen B. ... one-on-one meetings during the day. An audio ...
(Date:11/21/2014)... LAVAL, QC , Nov. 20, 2014 /CNW Telbec/ ... pleased to announce the following appointments: ... leadership team in the newly created role of Chief ... a BioPhotonic system using topical photoconverter gel for the ... as surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... , 21. November 2014 Michael DeMarco ... am Morgen des 14. Februar 2014 zugetragen hat. Seine ... kaum vergessen. Video - http://youtu.be/5cVoMCe0uiE ... dabei war, mein morgendliches Training zu machen", erzählt ... der Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. Ich ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm developing vaccines to ... announced that the NIH-funded HIV Vaccine Trials Network (HVTN) ... the company,s second-generation HIV vaccine. The second-generation vaccine is ... a Phase 2a clinical trial) except for the inclusion ...
... -- Gentech Pharmaceutical announced today that Dr. Stan Headley ... PhenTabz and ADDTabz ... the world of Integrative Medicine. He holds a Doctorate of ... family medicine at Creighton University School of Medicine and St. ...
Cached Medicine Technology:HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz 2
(Date:11/21/2014)... (HealthDay News) -- The cost of diabetes care in ... years, climbing to more than $322 billion annually, a ... were seen with prediabetes care, which have risen 74 ... the researchers added. In 2012, excess medical costs ... $1,000 for every American. That total includes $244 billion ...
(Date:11/21/2014)... Nov. 21, 2014 (HealthDay News) -- Scientists say they,ve mapped ... extracted from a British man,s brain, in hopes it might ... Nov. 21 in the journal Genome Biology , the ... man of Chinese ethnicity. "This infection is so rare ... was not diagnosed ... until the worm was pulled out ...
(Date:11/21/2014)... 21, 2014 MLF Biotech, Inc. has ... . Liv-Pro® Probiotics for Pets helps maintain digestive health ... a pet's intestinal flora after it experiences a period ... Liv-Pro Probiotics for Pets is a proprietary blend of ... seven live active bacteria strains that are safe and ...
(Date:11/21/2014)... November 21, 2014 Saint Luke’s ... With The Guidelines®–Heart Failure Gold-Plus Quality Achievement Award ... the American Heart Association/American College of Cardiology Foundation ... patients. , Get With The Guidelines–Heart Failure is ... provide the most up-to-date, research-based guidelines with the ...
(Date:11/21/2014)... Big Bud Farms announced today that ... Innovations with Ed Begley Jr., airing via Discovery Channel ... Big Bud Farms, growers of legal medical marijuana, provide ... of medical marijuana. , This segment of Innovations takes ... of products for medicating. Viewers will learn about the ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2
... found that the frequency with which critically-ill patients developed ... multidisciplinary medical center such as Mayo Clinic compared to ... National Healthcare Safety Network (NHSN). This is good news ... generally strong across the U.S. in intensive care units, ...
... children becoming unconscious after swallowing Aqua Dots beads led to ... the time, it was widely reported that the potentially toxic ... benign but more expensive 1,5-pentanediol (PD) in the manufacture of ... Suchard of the University of California, Irvine confirms these reports, ...
... Nancy Pelosi,issued the following statement today following reports on ... health has been met with great concern., "Senator ... Americans and a,great fighter for America,s children, workers and ... serve him well in this,challenge., "Our thoughts and ...
... spine conference and exhibition draws specialists from across the ... ... Medical Werks, a leading provider of,ceramic components for motion preserving, total disc ... be held in Geneva, Switzerland, May 26-31., The foremost scientific societies ...
... of,America, Inc. today announced that Lindsay Goldberg has ... will use the funds to close,several identified acquisitions ... http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO ), Ambulatory Services of ... care services in partnership with physicians. In,December 2007, ...
... Foundation,today released the following statement by its founder and ... learned today that Senator Kennedy, a champion for healthcare ... himself facing this,disease. I have no doubt that Senator ... strength that have shaped his lifelong service to this,nation ...
Cached Medicine News:Health News:Intensive care units' prevention of pneumonia in critically-ill patients generally strong 2Health News:Study finds that recalled Aqua Dots did contain poisonous chemical 2Health News:C5 Medical Werks Joins in Sponsoring SpineWeek 2008 in Geneva, Switzerland 2Health News:Ambulatory Services of America, Inc. Announces Investment by Lindsay Goldberg 2
... surgery, the Alexis Wound Retractor provides ... from contamination. For open surgery, the ... minimizing the incision size. For laparoscopic ... in offering retraction and protection when ...
... Concept is a revolutionary motorized electronic ... in mind, Pipetman Concept features exclusive ... connectionthe only one of its kind ... Diamond Tips from Gilson, this product ...
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
... Wireless, internet-based alarm/monitoring ... compliance and security ... system. The Celaris ... incorporates communication technology, ...
Medicine Products: